Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001209191-21-054833

President and CEO acquired 320,312 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Domzalski David · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-02 Grant or award : show line 1 in the form +320,312 775,911 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-02 Grant or award : show line 2 in the form Stock Options +320,313 320,313 D
Loading xslF345X03/doc4.xml…